What are the Challenges in Targeting Direct Repair in Cancer Therapy?
While targeting direct repair mechanisms offers therapeutic potential, it also presents challenges. Inhibiting these pathways could lead to increased toxicity in normal cells, as they also rely on these mechanisms to maintain genomic stability. Therefore, developing targeted therapies that selectively inhibit repair mechanisms in cancer cells while sparing normal cells is a significant area of ongoing research.
